Rafeh Naqash Shares Article on Immune Checkpoint Inhibitors For Patients With Autoimmune Neurologic Disorders
Rafeh Naqash, Assistant Professor at OU Health Stephenson Cancer Center and 2025 Yvonne ‘Mentorship’ Award Winner, shared a post on X:
“Immune Checkpoint Inhibitors for Patients With Autoimmune Neurologic Disorders. Fantastic realworld collaboration on a clinically relevant Q, “
Title: Immune Checkpoint Inhibitors for Patients With Preexisting Autoimmune Neurologic Disorders.
Authors: Kylie Fletcher, Marc Machaalani, Razane El Hajj Chehade, Amin H. Nassar, Rashad Nawfal, Michael Manos, Alexander M. Menzies, Frank Aboubakar-Nana, Jessica C. Hassel, David J. Pinato, Alexandra Johnson, Anna C. Olsson-Brown, Matteo S. Carlino, Andrea Malgeri, Alessio Cortellini, Aditi Singh, Kaushal Parikh, So Yeon Kim, Abdul Rafeh Naqash, Georgina V. Long, Pavan Challa, Toni K. Choueiri, Elad Sharon, Shailee Shah, Douglas B. Johnson
You can read the Full Article on JAMA Network.
More posts featuring Rafeh Naqash.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023